Revance Therapeutics Inc.

September 11, 2022

FDA Approves Daxxify, a New Anti-Wrinkle Drug

Treatment lasts six months for half of users, company studies have shown, marking the first major advancement in facial injections in decades. Source link
gdpr-image
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more